The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

News
Essay prize 2020 header
Wednesday 4 March 2020
Calling all medical students! How would you rate your knowledge of ovarian cancer? You may have been fortunate enough to meet a woman living with ovarian cancer during your O&G or oncology rotation, or, perhaps you’ve had a lecture or teaching session with a consultant gynaeoncologist. More...
News
Monday 9 December 2019
The Scottish Medicines Consortium (SMC) has joined the National Institute for Health and Care Excellence (NICE) by approving a breakthrough ovarian cancer drug from the first round of treatment, meaning it is now available across the UK. Olaparib (Lynparza®) is one of a new generation of drugs...
News
NHS ovarian cancer awareness campaign was a success
Thursday 31 October 2019
Public cancer awareness campaigns do work, according to encouraging evidence published this week. Target Ovarian Cancer has had a first look at results from a Be Clear on Cancer awareness campaign featuring a key symptom of ovarian cancer - bloating. The campaign ran in North West England from...
News
researcher looking at agar plates
Friday 11 October 2019
The National Institute for Health and Care Excellence (NICE) today announced a third ovarian cancer drug, PARP inhibitor rucaparib (Rubraca®), is now available to women with ovarian cancer from after a second round of chemotherapy. It will be available both for women who have a BRCA1 or BRCA2...

Pages